A broad anti-anti-CRISPR strategy

Yi Zhang,Yue Feng

DOI: https://doi.org/10.1038/s41589-024-01743-w

IF: 14.8

2024-10-16

Nature Chemical Biology

Abstract:Prokaryotic CRISPR–Cas systems are counteracted by phage-encoded anti-CRISPR elements, and how they protect themselves remains enigmatic. A study shows that CRISPR-repressed toxins defend CRISPR–Cas against anti-CRISPR proteins or RNAs by inducing abortive infection.

biochemistry & molecular biology

What problem does this paper attempt to address?

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Xian Shu,Rui Wang,Zhihua Li,Qiong Xue,Jiajun Wang,Jingfang Liu,Feiyue Cheng,Chao Liu,Huiwei Zhao,Chunyi Hu,Jie Li,Songying Ouyang,Ming Li

DOI: https://doi.org/10.1101/2024.01.05.574328

2024-01-05

Abstract:Prokaryotic CRISPR-Cas systems are highly vulnerable to phage-encoded anti-CRISPR (Acr) factors. How CRISPR-Cas systems protect themselves remains unclear. Here, we uncovered a broad-spectrum anti-anti-CRISPR strategy involving a phage-derived toxic protein. Transcription of this toxin is normally reppressed by the CRISPR-Cas effector, but is activated to halt cell division when the effector is inhibited by any anti-CRISPR proteins or RNAs. We showed that this abortive infection-like effect efficiently expels Acr elements from bacterial population. Furthermore, we exploited this anti-anti-CRISPR mechanism to develop a screening method for specific Acr candidates for a CRISPR-Cas system, and successfully identified two distinct Acr proteins that enhance the binding of CRISPR effector to non-target DNA. Our data highlight the broad-spectrum role of CRISPR-repressed toxins in counteracting various types of Acr factors, which illuminates that the regulatory function of CRISPR-Cas confers host cells herd immunity against Acr-encoding genetic invaders, no matter they are CRISPR-targeted or not.

Microbiology
Anti-CRISPRs deconstruct bacterial defense

Nils Birkholz,Peter C Fineran

DOI: https://doi.org/10.1016/j.molcel.2024.08.008

2024-09-05

Abstract:Deploying anti-CRISPR proteins is a potent strategy used by phages to inhibit bacterial CRISPR-Cas defense. In a new Nature paper, Trost et al.1 discover and characterize an exciting anti-CRISPR mechanism with possible implications beyond this microscopic arms race.
CRISPR-repressed toxin-antitoxin provides herd immunity against anti-CRISPR elements

Xian Shu,Rui Wang,Zhihua Li,Qiong Xue,Jiajun Wang,Jingfang Liu,Feiyue Cheng,Chao Liu,Huiwei Zhao,Chunyi Hu,Jie Li,Songying Ouyang,Ming Li

DOI: https://doi.org/10.1038/s41589-024-01693-3

2024-07-29

Abstract:Prokaryotic clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems are highly vulnerable to phage-encoded anti-CRISPR (Acr) factors. How CRISPR-Cas systems protect themselves remains unclear. Here we uncovered a broad-spectrum anti-anti-CRISPR strategy involving a phage-derived toxic protein. Transcription of this toxin is normally repressed by the CRISPR-Cas effector but is activated to halt cell division when the effector is inhibited by any anti-CRISPR proteins or RNAs. We showed that this abortive infection-like effect efficiently expels Acr elements from bacterial population. Furthermore, we exploited this anti-anti-CRISPR mechanism to develop a screening method for specific Acr candidates for a CRISPR-Cas system and successfully identified two distinct Acr proteins that enhance the binding of CRISPR effector to nontarget DNA. Our data highlight the broad-spectrum role of CRISPR-repressed toxins in counteracting various types of Acr factors. We propose that the regulatory function of CRISPR-Cas confers host cells herd immunity against Acr-encoding genetic invaders whether they are CRISPR targeted or not.
Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Lingguang Yang,Yi Zhang,Peipei Yin,Yue Feng

DOI: https://doi.org/10.1080/15476286.2021.1985347

2021-10-04

RNA Biology

Abstract:Phage infection is one of the major threats to prokaryotic survival, and prokaryotes in turn have evolved multiple protection approaches to fight against this challenge. Various delicate mechanisms have been discovered from this eternal arms race, among which the CRISPR-Cas systems are the prokaryotic adaptive immune systems and phages evolve diverse anti-CRISPR (Acr) proteins to evade this immunity. Until now, about 90 families of Acr proteins have been identified, out of which 24 families were verified to fight against subtype I-F CRISPR-Cas systems. Here, we review the structural and biochemical mechanisms of the characterized type I-F Acr proteins, classify their inhibition mechanisms into two major groups and provide insights for future studies of other Acr proteins. Understanding Acr proteins in this context will lead to a variety of practical applications in genome editing and also provide exciting insights into the molecular arms race between prokaryotes and phages.

biochemistry & molecular biology
Anti-CRISPR: discovery, mechanism and function

April Pawluk,Alan R. Davidson,Karen L. Maxwell

DOI: https://doi.org/10.1038/nrmicro.2017.120

IF: 88.1

2017-10-24

Nature Reviews Microbiology

Abstract:CRISPR–Cas adaptive immune systems are widespread in prokaryotes. In this Progress article, Maxwell and colleagues highlight how phages and other mobile genetic elements inactivate CRISPR–Cas systems using anti-CRISPR proteins and outline evolutionary and biotechnological implications of anti-CRISPR protein activity.

microbiology
Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Qiong Liu,Hongxia Zhang,Xiaotian Huang

DOI: https://doi.org/10.1111/febs.15139

Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas adaptive immune defense systems, which are widely distributed in bacteria and Archaea, can provide sequence-specific protection against foreign DNA or RNA in some cases. However, the evolution of defense systems in bacterial hosts did not lead to the elimination of phages, and some phages carry anti-CRISPR genes that encode products that bind to the components mediating the defense mechanism and thus antagonize CRISPR-Cas immune systems of bacteria. Given the extensive application of CRISPR-Cas9 technologies in gene editing, in this review, we focus on the anti-CRISPR proteins (Acrs) that inhibit CRISPR-Cas systems for gene editing. We describe the discovery of Acrs in immune systems involving type I, II, and V CRISPR-Cas immunity, discuss the potential function of Acrs in inactivating type II and V CRISPR-Cas systems for gene editing and gene modulation, and provide an outlook on the development of important biotechnology tools for genetic engineering using Acrs.
Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Fei Zhang,Guoxu Song,Yong Tian

DOI: https://doi.org/10.1002/ame2.12069

2019-05-29

Animal Models and Experimental Medicine

Abstract:CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR associated protein) systems serve as the adaptive immune system by which prokaryotes defend themselves against phages. It has also been developed into a series of powerful gene-editing tools. As the natural inhibitors of CRISPR-Cas systems, anti-CRISPRs (Acrs) can be used as the "off-switch" for CRISPR-Cas systems to limit the off-target effects caused by Cas9. Since the discovery of CRISPR-Cas systems, much research has focused on the identification, mechanisms and applications of Acrs. In light of the rapid development and scientific significance of this field, this review summarizes the history and research status of Acrs, and considers future applications.
Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins

Yuwei Zhu,Fan Zhang,Zhiwei Huang

DOI: https://doi.org/10.1186/s12915-018-0504-9

IF: 7.364

2018-03-19

BMC Biology

Abstract:A molecular arms race is progressively being unveiled between prokaryotes and viruses. Prokaryotes utilize CRISPR-mediated adaptive immune systems to kill the invading phages and mobile genetic elements, and in turn, the viruses evolve diverse anti-CRISPR proteins to fight back. The structures of several anti-CRISPR proteins have now been reported, and here we discuss their structural features, with a particular emphasis on topology, to discover their similarities and differences. We summarize the CRISPR-Cas inhibition mechanisms of these anti-CRISPR proteins in their structural context. Considering anti-CRISPRs in this way will provide important clues for studying their origin and evolution.

biology
Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

Caroline Mahendra,Kathleen A Christie,Beatriz A Osuna,Rafael Pinilla-Redondo,Benjamin P Kleinstiver,Joseph Bondy-Denomy

DOI: https://doi.org/10.1038/s41564-020-0692-2

Abstract:CRISPR-Cas adaptive immune systems protect bacteria and archaea against their invading genetic parasites, including bacteriophages/viruses and plasmids. In response to this immunity, many phages have anti-CRISPR (Acr) proteins that inhibit CRISPR-Cas targeting. To date, anti-CRISPR genes have primarily been discovered in phage or prophage genomes. Here, we uncovered acr loci on plasmids and other conjugative elements present in Firmicutes using the Listeria acrIIA1 gene as a marker. The four identified genes, found in Listeria, Enterococcus, Streptococcus and Staphylococcus genomes, can inhibit type II-A SpyCas9 or SauCas9, and are thus named acrIIA16-19. In Enterococcus faecalis, conjugation of a Cas9-targeted plasmid was enhanced by anti-CRISPRs derived from Enterococcus conjugative elements, highlighting a role for Acrs in the dissemination of plasmids. Reciprocal co-immunoprecipitation showed that each Acr protein interacts with Cas9, and Cas9-Acr complexes were unable to cleave DNA. Northern blotting suggests that these anti-CRISPRs manipulate single guide RNA length, loading or stability. Mirroring their activity in bacteria, AcrIIA16 and AcrIIA17 provide robust and highly potent broad-spectrum inhibition of distinct Cas9 proteins in human cells (for example, SpyCas9, SauCas9, SthCas9, NmeCas9 and CjeCas9). This work presents a focused analysis of non-phage Acr proteins, demonstrating a role in horizontal gene transfer bolstered by broad-spectrum CRISPR-Cas9 inhibition.
If you can't beat them, join them: Anti-CRISPR proteins derived from CRISPR-associated genes

Charlie Y. Mo

DOI: https://doi.org/10.1016/j.chom.2024.10.009

IF: 31.316

2024-11-14

Cell Host & Microbe

Abstract:Bacteriophages have evolved numerous mechanisms to evade targeting by CRISPR-Cas defense systems. However, the evolutionary origin of these so-called "anti-CRISPRs" remains poorly understood. In a recent issue of Nature, Katz et al. provide evidence that some anti-CRISPRs were derived from genes of the CRISPR-Cas systems themselves.

microbiology,virology,parasitology
Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

Chao Liu,Rui Wang,Zhihua Li,Wenhe Wang,Jiachen Yao,Feiyue Cheng,Xiaoyu Du,Linlin Guan,Mario Rodriguez Mestre,Qiong Xue,Jun Du,Jing Xu,Tao Zhou,Xian Shu,Huiwei Zhao,Yue Feng,Rafael Pinilla-Redondo,Ming Li

DOI: https://doi.org/10.1101/2024.10.29.618823

2024-11-02

Abstract:In prokaryotes, arrayed CRISPR RNAs (crRNAs) guide Cas proteins to destroy phage DNA/RNA, while solitary crRNA-like RNAs (crlRNAs) program Cas proteins for auto-regulation or to control abortive infection (Abi)-inducing toxins that activate when CRISPR-Cas fails. Here, we report that phages exploit crlRNA mimics to hijack these multi-layered host defenses. Pseudomonas aeruginosa phages use crlRNAs to thwart CRISPR-Cas immunity by inhibiting Cas expression, or to block Abi by silencing an unprecedented RNA toxin that features consecutive proline codons. Remarkably, the anti-CRISPR protein AcrIF24 selectively inhibits Cas proteins loaded with host crRNAs/crlRNAs, while allowing those complexed with viral crlRNAs to synergistically block Abi responses, as viral crlRNAs have co-adaptively evolved shorter spacer sequences. Furthermore, viral crlRNAs frequently organize as multiplexed arrays, mirroring the architecture of bacterial CRISPRs. Our findings showcase how phage RNAs hijack Cas proteins to silence multi-layered bacterial defenses, and highlight the delicate synergy between RNA and protein-based anti-CRISPR strategies.

Microbiology
The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Kevin J Forsberg,Danica T Schmidtke,Rachel Werther,Ruben V Uribe,Deanna Hausman,Morten O A Sommer,Barry L Stoddard,Brett K Kaiser,Harmit S Malik

DOI: https://doi.org/10.1371/journal.pbio.3001428

2021-10-13

Abstract:To overcome CRISPR-Cas defense systems, many phages and mobile genetic elements (MGEs) encode CRISPR-Cas inhibitors called anti-CRISPRs (Acrs). Nearly all characterized Acrs directly bind Cas proteins to inactivate CRISPR immunity. Here, using functional metagenomic selection, we describe AcrIIA22, an unconventional Acr found in hypervariable genomic regions of clostridial bacteria and their prophages from human gut microbiomes. AcrIIA22 does not bind strongly to SpyCas9 but nonetheless potently inhibits its activity against plasmids. To gain insight into its mechanism, we obtained an X-ray crystal structure of AcrIIA22, which revealed homology to PC4-like nucleic acid-binding proteins. Based on mutational analyses and functional assays, we deduced that acrIIA22 encodes a DNA nickase that relieves torsional stress in supercoiled plasmids. This may render them less susceptible to SpyCas9, which uses free energy from negative supercoils to form stable R-loops. Modifying DNA topology may provide an additional route to CRISPR-Cas resistance in phages and MGEs.
Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Adair L Borges,Jenny Y Zhang,MaryClare F Rollins,Beatriz A Osuna,Blake Wiedenheft,Joseph Bondy-Denomy

DOI: https://doi.org/10.1016/j.cell.2018.06.013

IF: 64.5

2018-08-09

Cell

Abstract:Bacteria utilize CRISPR-Cas adaptive immune systems for protection from bacteriophages (phages), and some phages produce anti-CRISPR (Acr) proteins that inhibit immune function. Despite thorough mechanistic and structural information for some Acr proteins, how they are deployed and utilized by a phage during infection is unknown. Here, we show that Acr production does not guarantee phage replication when faced with CRISPR-Cas immunity, but instead, infections fail when phage population numbers fall below a critical threshold. Infections succeed only if a sufficient Acr dose is contributed to a single cell by multiple phage genomes. The production of Acr proteins by phage genomes that fail to replicate leave the cell immunosuppressed, which predisposes the cell for successful infection by other phages in the population. This altruistic mechanism for CRISPR-Cas inhibition demonstrates inter-virus cooperation that may also manifest in other host-parasite interactions.
Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Sarah Camara-Wilpert,David Mayo-Muñoz,Jakob Russel,Robert D. Fagerlund,Jonas S. Madsen,Peter C. Fineran,Søren J. Sørensen,Rafael Pinilla-Redondo

DOI: https://doi.org/10.1038/s41586-023-06612-5

IF: 64.8

2023-10-19

Nature

Abstract:Many bacteria use CRISPR–Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids 1 . In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity 2,3 . Here we unveil a distinct type of CRISPR–Cas Inhibition strategy that is based on small non-coding R NA a nti- CR ISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units 4 . We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR–Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR–Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes 5 . Functional testing of nine candidates spanning the two CRISPR–Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications 6 .

multidisciplinary sciences
Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

Ning Jia,Dinshaw J. Patel

DOI: https://doi.org/10.1038/s41580-021-00371-9

IF: 113.915

2021-06-04

Nature Reviews Molecular Cell Biology

Abstract:CRISPR loci and Cas proteins provide adaptive immunity in prokaryotes against invading bacteriophages and plasmids. In response, bacteriophages have evolved a broad spectrum of anti-CRISPR proteins (anti-CRISPRs) to counteract and overcome this immunity pathway. Numerous anti-CRISPRs have been identified to date, which suppress single-subunit Cas effectors (in CRISPR class 2, type II, V and VI systems) and multisubunit Cascade effectors (in CRISPR class 1, type I and III systems). Crystallography and cryo-electron microscopy structural studies of anti-CRISPRs bound to effector complexes, complemented by functional experiments in vitro and in vivo, have identified four major CRISPR–Cas suppression mechanisms: inhibition of CRISPR–Cas complex assembly, blocking of target binding, prevention of target cleavage, and degradation of cyclic oligonucleotide signalling molecules. In this Review, we discuss novel mechanistic insights into anti-CRISPR function that have emerged from X-ray crystallography and cryo-electron microscopy studies, and how these structures in combination with function studies provide valuable tools for the ever-growing CRISPR–Cas biotechnology toolbox, to be used for precise and robust genome editing and other applications.

cell biology
CRISPR-Cas Controls Cryptic Prophages

Sooyeon Song,Ekaterina Semenova,Konstantin Severinov,Laura Fernández-García,Michael J Benedik,Toshinari Maeda,Thomas K Wood

DOI: https://doi.org/10.3390/ijms232416195

2022-12-19

Abstract:The bacterial archetypal adaptive immune system, CRISPR-Cas, is thought to be repressed in the best-studied bacterium, Escherichia coli K-12. We show here that the E. coli CRISPR-Cas system is active and serves to inhibit its nine defective (i.e., cryptic) prophages. Specifically, compared to the wild-type strain, reducing the amounts of specific interfering RNAs (crRNA) decreases growth by 40%, increases cell death by 700%, and prevents persister cell resuscitation. Similar results were obtained by inactivating CRISPR-Cas by deleting the entire 13 spacer region (CRISPR array); hence, CRISPR-Cas serves to inhibit the remaining deleterious effects of these cryptic prophages, most likely through CRISPR array-derived crRNA binding to cryptic prophage mRNA rather than through cleavage of cryptic prophage DNA, i.e., self-targeting. Consistently, four of the 13 E. coli spacers contain complementary regions to the mRNA sequences of seven cryptic prophages, and inactivation of CRISPR-Cas increases the level of mRNA for lysis protein YdfD of cryptic prophage Qin and lysis protein RzoD of cryptic prophage DLP-12. In addition, lysis is clearly seen via transmission electron microscopy when the whole CRISPR-Cas array is deleted, and eliminating spacer #12, which encodes crRNA with complementary regions for DLP-12 (including rzoD), Rac, Qin (including ydfD), and CP4-57 cryptic prophages, also results in growth inhibition and cell lysis. Therefore, we report the novel results that (i) CRISPR-Cas is active in E. coli and (ii) CRISPR-Cas is used to tame cryptic prophages, likely through RNAi, i.e., unlike with active lysogens, active CRISPR-Cas and cryptic prophages may stably co-exist.
Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Sungwon Hwang,Chuxi Pan,Bianca Garcia,Alan R Davidson,Trevor F Moraes,Karen L Maxwell

DOI: https://doi.org/10.1016/j.jmb.2021.167420

2022-03-15

Abstract:Phages, plasmids, and other mobile genetic elements express inhibitors of CRISPR-Cas immune systems, known as anti-CRISPR proteins, to protect themselves from targeted destruction. These anti-CRISPR proteins have been shown to function through very diverse mechanisms. In this work we investigate the activity of an anti-CRISPR isolated from a prophage in Haemophilus parainfluenzae that blocks CRISPR-Cas9 DNA cleavage activity. We determine the three-dimensional crystal structure of AcrIIC4Hpa and show that it binds to the Cas9 Recognition Domain. This binding does not prevent the Cas9-anti-CRISPR complex from interacting with target DNA but does inhibit DNA cleavage. AcrIIC4Hpa likely acts by blocking the conformational changes that allow the HNH and RuvC endonuclease domains to contact the DNA sites to be nicked.
Diverse viral cas genes antagonize CRISPR immunity

Mark A Katz,Edith M Sawyer,Luke Oriolt,Albina Kozlova,Madison C Williams,Shally R Margolis,Matthew Johnson,Joseph Bondy-Denomy,Alexander J Meeske

DOI: https://doi.org/10.1038/s41586-024-07923-x

IF: 64.8

Nature

Abstract:Prokaryotic CRISPR-Cas immunity is subverted by anti-CRISPRs (Acrs), which inhibit Cas protein activities when expressed during the phage lytic cycle or from resident prophages or plasmids1. Acrs often bind to specific cognate Cas proteins, and hence inhibition is typically limited to a single CRISPR-Cas subtype2. Furthermore, although acr genes are frequently organized together in phage-associated gene clusters3, how such inhibitors initially evolve has remained unclear. Here we investigated the Acr content and inhibition specificity of diverse Listeria isolates, which naturally harbour four CRISPR-Cas systems (types I-B, II-A, II-C and VI-A). We observed widespread antagonism of CRISPR, which we traced to 11 previously unknown and 4 known acr gene families encoded by endogenous mobile elements. Among these were two Acrs that possess sequence homology to type I-B Cas proteins, one of which assembles into a defective interference complex. Surprisingly, an additional type I-B Cas homologue did not affect type I immunity, but instead inhibited the RNA-targeting type VI CRISPR system by means of CRISPR RNA (crRNA) degradation. By probing viral sequence databases, we detected abundant orphan cas genes located within putative anti-defence gene clusters. Among them, we verified the activity of a particularly broad-spectrum cas3 homologue that inhibits type I-B, II-A and VI-A CRISPR immunity. Our observations provide direct evidence of Acr evolution by cas gene co-option, and new genes with potential for broad-spectrum control of genome editing technologies.
A Broad-Spectrum Inhibitor of CRISPR-Cas9

Lucas B Harrington,Kevin W Doxzen,Enbo Ma,Jun-Jie Liu,Gavin J Knott,Alireza Edraki,Bianca Garcia,Nadia Amrani,Janice S Chen,Joshua C Cofsky,Philip J Kranzusch,Erik J Sontheimer,Alan R Davidson,Karen L Maxwell,Jennifer A Doudna

DOI: https://doi.org/10.1016/j.cell.2017.07.037

IF: 64.5

2017-09-07

Cell

Abstract:CRISPR-Cas9 proteins function within bacterial immune systems to target and destroy invasive DNA and have been harnessed as a robust technology for genome editing. Small bacteriophage-encoded anti-CRISPR proteins (Acrs) can inactivate Cas9, providing an efficient off switch for Cas9-based applications. Here, we show that two Acrs, AcrIIC1 and AcrIIC3, inhibit Cas9 by distinct strategies. AcrIIC1 is a broad-spectrum Cas9 inhibitor that prevents DNA cutting by multiple divergent Cas9 orthologs through direct binding to the conserved HNH catalytic domain of Cas9. A crystal structure of an AcrIIC1-Cas9 HNH domain complex shows how AcrIIC1 traps Cas9 in a DNA-bound but catalytically inactive state. By contrast, AcrIIC3 blocks activity of a single Cas9 ortholog and induces Cas9 dimerization while preventing binding to the target DNA. These two orthogonal mechanisms allow for separate control of Cas9 target binding and cleavage and suggest applications to allow DNA binding while preventing DNA cutting by Cas9.
A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing

Nisha Choudhary,Dipty Tandi,Rakesh Kumar Verma,Virendra Kumar Yadav,Naveen Dhingra,Tathagata Ghosh,Mahima Choudhary,Rajarshi K. Gaur,Magda H. Abdellatif,Amel Gacem,Lienda Bashier Eltayeb,Mohammed S. Alqahtani,Krishna Kumar Yadav,Byong-Hun Jeon

DOI: https://doi.org/10.3389/fpls.2023.1164461

IF: 5.6

2023-06-24

Frontiers in Plant Science

Abstract:The development of precise and controlled CRISPR-Cas tools has been made possible by the discovery of protein inhibitors of CRISPR-Cas systems, called anti-CRISPRs (Acrs). The Acr protein has the ability to control off-targeted mutations and impede Cas protein–editing operations. Acr can help with selective breeding, which could help plants and animals improve their valuable features. In this review, the Acr protein–based inhibitory mechanisms that have been adopted by several Acrs, such as (a) the interruption of CRISPR-Cas complex assembly, (b) interference with target DNA binding, (c) blocking of target DNA/RNA cleavage, and (d) enzymatic modification or degradation of signalling molecules, were discussed. In addition, this review emphasizes the applications of Acr proteins in the plant research.

plant sciences

A broad anti-anti-CRISPR strategy

CRISPR-repressed toxin-antitoxin provides population-level immunity against diverse anti-CRISPR elements

Anti-CRISPRs deconstruct bacterial defense

CRISPR-repressed toxin-antitoxin provides herd immunity against anti-CRISPR elements

Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins

Anti-CRISPR: discovery, mechanism and function

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems

Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins

Broad-spectrum anti-CRISPR proteins facilitate horizontal gene transfer

If you can't beat them, join them: Anti-CRISPR proteins derived from CRISPR-associated genes

Phage CRISPR-like regulatory RNAs silence bacterial adaptive and innate immunity

The novel anti-CRISPR AcrIIA22 relieves DNA torsion in target plasmids and impairs SpyCas9 activity

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs

Structure-based functional mechanisms and biotechnology applications of anti-CRISPR proteins

CRISPR-Cas Controls Cryptic Prophages

Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa

Diverse viral cas genes antagonize CRISPR immunity

A Broad-Spectrum Inhibitor of CRISPR-Cas9

A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing